It is tempting to speculate that in response to an inflammatory response, the tumor cells assemble both positive (NF-κB) and negative (LSD1) transcription factors on the promoters of proinflammatory genes, followed by demethylation of H3K4me3 by LSD1, leading to blockade of NF-κB binding. This evidence concerns the gene KDM1A and neoplasm.